MDXH
MDxHealth SA
0.5969$
+4.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.9% | -5.7% | +7.5% | +20.3% | -0.1% | +11.1% | -19.6% | +9.7% | -4.1% | +0.0% | -10.7% | |
| – | -16.4% | -16.2% | +27.9% | +71.6% | -4.7% | +29.1% | -37.7% | +8.3% | -8.3% | +0.0% | -19.4% | |
| – | -31.6% | -35.2% | +47.3% | +130.8% | -5.0% | +40.3% | -50.0% | -2.4% | -9.3% | +0.0% | -33.8% | |
| – | -31.6% | -35.2% | +47.3% | +130.8% | -5.0% | +40.3% | -50.0% | -2.4% | -9.3% | +0.0% | -33.8% | |
| – | +31.5% | +12.4% | +6.2% | +11.4% | -3.1% | +7.0% | +1.1% | +16.1% | -19.5% | +0.0% | +1.7% | |
| – | -3.1% | +9.5% | +23.3% | +16.8% | -11.7% | -14.0% | +10.0% | +66.3% | +10.8% | +0.0% | -4.6% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +3.1% | +5.1% | +0.0% | +0.8% | |
| – | -0.2% | -1.3% | -1.1% | -3.1% | -3.2% | -3.3% | -3.4% | +8.8% | -4.5% | +0.0% | -6.9% | |
| – | +3.4% | +0.7% | +13.8% | +0.5% | +1.5% | +18.5% | -16.2% | +14.9% | -1.5% | +0.0% | +1.5% | |
| – | +3.6% | -2.9% | +137.5% | +1.2% | -6.3% | +1.2% | -4.5% | +24.2% | -3.2% | +0.0% | -24.5% | |
| – | +4.3% | +4.1% | +2.1% | -14.6% | -12.5% | -7.7% | -5.4% | +33.4% | -3.2% | +0.0% | -5.0% | |
| – | -1.5% | -0.6% | +38.4% | -14.4% | -23.0% | -5.6% | -10.8% | +39.4% | +10.0% | +0.0% | +2.3% | |
| – | +0.6% | +0.6% | +43.4% | -0.9% | +0.2% | +47.9% | +0.4% | +0.4% | +0.4% | +25.9% | +0.5% | |
| – | -59.6% | -113.5% | – | – | -12.7% | -59.8% | -114.8% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.9% | +0.0% | 0.0% | +73.3% | +3.3% | -0.8% | +0.0% | +3.3% | -0.1% | +0.0% | +4.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.